124 related articles for article (PubMed ID: 2142165)
1. The urinary dehydroepiandrosterone, androsterone and etiocholanolone excretion of healthy women and women with benign and malignant breast disease.
Ivanović S; Agbaba D; Zivanov-Stakić D; Konstantinović I
J Clin Pharm Ther; 1990 Jun; 15(3):213-9. PubMed ID: 2142165
[TBL] [Abstract][Full Text] [Related]
2. Some aspects of the circadian rhythm of the urinary excretion of etiocholanolone, androsterone and dehydroepiandrosterone.
van Voorst tot Voorst EJ
J Clin Chem Clin Biochem; 1982 Jan; 20(1):25-8. PubMed ID: 6461715
[TBL] [Abstract][Full Text] [Related]
3. Benign and malignant breast disease in South Wales: a study of urinary steroids.
Cameron EH; Griffiths K; Gleave E; Stewart HJ; Forrest AP; Campbell H
Br Med J; 1970 Dec; 4(5738):768-71. PubMed ID: 4250592
[TBL] [Abstract][Full Text] [Related]
4. The excretion of 17-ketosteroids in patients suffering from mastopathia fibrocystica and mammary carcinomas.
Görlich M; Heise E; Pradja N; Hindy I
Arch Geschwulstforsch; 1975; 45(7):648-57. PubMed ID: 132149
[TBL] [Abstract][Full Text] [Related]
5. Effect of age, obesity, starvation, and changes in adrenocortical and ovarian activity on the urinary excretion of dehydroepiandrosterone relative to androsterone plus etiocholanolone: relevance to the measurement of breast cancer discriminants in women.
Metcalf MG
Clin Biochem; 1974 Jun; 7(2):119-30. PubMed ID: 4276446
[No Abstract] [Full Text] [Related]
6. [On the metabolism of phosphates and sulfates of androsterone and epiandrosterone].
Schubert K; Hobe G; Bacigalupo G
Endokrinologie; 1966 Aug; 50(3):138-44. PubMed ID: 4232576
[No Abstract] [Full Text] [Related]
7. Urinary excretion of 11-deoxy-17-ketosteroids by patients with breast cancer with or without ovulatory cycles.
Grattarola R
J Endocrinol; 1967 May; 38(1):77-8. PubMed ID: 4225834
[No Abstract] [Full Text] [Related]
8. [Influence of age and menopause duration on the excretion of steroid hormones in precancerous conditions and cancer of the breast].
Bogdanova AG
Vopr Onkol; 1974 Oct; 20(7):13-8. PubMed ID: 4277856
[No Abstract] [Full Text] [Related]
9. The relationship of urinary androgen metabolites to breast diseases including carcinoma.
Wetchler BB; McCarrick J; Allerhand J; Dreiling DA
Mt Sinai J Med; 1974; 41(5):682-6. PubMed ID: 4278335
[No Abstract] [Full Text] [Related]
10. Investigation of 17-ketosteriod excretion in mastopathia and premenopausal breast cancer.
Hindy I; Prajda N; Tapolcsányi L; Sellei C; Eckhardt S
Arch Geschwulstforsch; 1975; 45(5):453-6. PubMed ID: 129041
[TBL] [Abstract][Full Text] [Related]
11. Urinary 17-ketosteroid fractions in young patients with breast cancer.
Chiricuţă I; Frenkel Z; Muteanu S
Endocrinologie; 1978; 16(2):135-7. PubMed ID: 150018
[TBL] [Abstract][Full Text] [Related]
12. The determination of urinary androsterone, etiocholanolone, and dehydroepiandrosterone in the normal male rhesus monkey.
Tolson WW; Johnson TR; Mason JW
J Lab Clin Med; 1966 Dec; 68(6):981-90. PubMed ID: 4224475
[No Abstract] [Full Text] [Related]
13. Excretion of urinary 17-hydroxycorticosteroids and 11-deoxy-17-oxosteroids by women using steroidal contraceptives.
Bulbrook RD; Hayward JL
Lancet; 1969 Nov; 2(7629):1033-5. PubMed ID: 4187543
[No Abstract] [Full Text] [Related]
14. [Urinary 11-deoxy-17-ketosteroids in breast cancer patients considered in relation to the menstrual cycle: ovulatory and non ovulatory].
Grattarola R
Tumori; 1967; 53(2):129-39. PubMed ID: 4227798
[No Abstract] [Full Text] [Related]
15. Urinary 17-ketosteroid excretion of women with advanced breast cancer.
Kumaoka S; Sakauchi N; Abe O; Kusama M; Takatani O
J Clin Endocrinol Metab; 1968 May; 28(5):667-72. PubMed ID: 4231599
[No Abstract] [Full Text] [Related]
16. I. URINARY EXCRETION OF NEUTRAL 17-KETOSTEROIDS AND PREGNANDEIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE.
MARMORSTON J; CROWLEY LG; MYERS SM; STERN E; HOPKINS CE
Am J Obstet Gynecol; 1965 Jun; 92():447-59. PubMed ID: 14305945
[No Abstract] [Full Text] [Related]
17. [Urinary excretion of neutral 17-ketosteroids, androsterone and etiocholanolone in healthy women and women with early and advanced breast cancer].
Bacigalupo G; Lingk H
Arch Geschwulstforsch; 1968; 32(1):95-107. PubMed ID: 5678251
[No Abstract] [Full Text] [Related]
18. A comparison of urinary 17-hydroxycorticosteroid and 11-deoxy-17-oxosteroid excretion in obesity, in thyroid dysfunction and in early breast cancer.
Sneddon A; Steel JM; Strong JA
J Endocrinol; 1969 Feb; 43(2):48-9. PubMed ID: 4237784
[No Abstract] [Full Text] [Related]
19. [The use of thin layer chromatography for the separation and determination of etiocolanolone, androsterone and dehydroepiandrosterone in urine].
Rondini G; Belloni C; Pallucchini F
Minerva Pediatr; 1967 Sep; 19(39):1794-6. PubMed ID: 4240278
[No Abstract] [Full Text] [Related]
20. A comparative study of the urinary excretion of glucocorticoids and 11-deoxy-17-ketosteroids in a group of obese women.
Hendrikx A; Meulepas E; Heyns W; De Moor P
Ann Endocrinol (Paris); 1974; 35(4):508-20. PubMed ID: 4283406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
